Commissioned Colonel by the Governor of the Commonwealth of Kentucky USA in 2018 for outstanding personal and professional achievements. He is leading a translational research program in regenerative medicine and clinical trials addressing key questions in cardiology and transplantation. PI/co-PI on investigator-initiated projects, but also with major role/involvement and steering committees in international clinical trials leading to publications in high-impact journals and lectures worldwide. He is the director of cardiovascular medicine at the CHUM. He initiated COMPARE-AMI and IMPACT-CABG trials combining 80 patients treated with intracardiac transplantation of CD133+ stem cells to treat heart failure: first Canadian experience and a major milestone in the field. He possesses valuable and unique surgical skills in preclinical experimental models mimicking a variety of human diseases in both small and large animals. He set up various platforms for in vitro, ex vivo and in vivo experiments to study animals up to humans, at the cellular or whole organ levels and organ perfusion systems for the heart, the lungs and liver. Performing the lung transplantations at the CHUM, he initiated in 2014 with Dr. Pasquale Ferraro (chair in lung transplant) the program of ex-vivo lung perfusion both clinically and in large animals with more than 130 procedures so far. Dr. Noiseux has been very successful in developing cutting edge translational research for innovative therapies to reduce ischemia-reperfusion injury to increase the number and quality of organs for transplantation